Spotlight On Non-Small Cell Lung Cancer
Up to 85 percent of all lung cancer cases are characterized as non-small cell lung cancer, underscoring the importance of keeping up to date on the latest diagnostic and treatment advances. That’s why this Spotlight on Non-Small Cell Lung Cancer brings together leading oncologists and other allied healthcare professionals to discuss key research updates and other novel insights.
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Geoffrey Oxnard, MD
Integrating Molecular Testing into NSCLC Care
Project Oncology®Integrating Molecular Testing into NSCLC Care
Geoffrey Oxnard, MD
Smarter Screening for Non-Small Cell Lung Cancer
Project Oncology®Smarter Screening for Non-Small Cell Lung Cancer
Jobelle Baldonado, MD
A New Era of Hope in Non-Small Cell Lung Cancer Care
Project Oncology®A New Era of Hope in Non-Small Cell Lung Cancer Care
Geoffrey Oxnard, MD
Improving Adherence and Toxicity Monitoring in NSCLC Care
Project Oncology®Improving Adherence and Toxicity Monitoring in NSCLC Care
Raghava Reddy Induru, MD
The Evolving Role of Antibody-Drug Conjugates in NSCLC Care
Project Oncology®The Evolving Role of Antibody-Drug Conjugates in NSCLC Care
Raghava Reddy Induru, MD
- advertisement
- 09/01/2026
- 08/17/2026
- 07/31/2026
- 07/31/2026
- 06/15/2026
- 06/08/2026